Hsu, Ching-Sheng
Chao, You-Chen
Lin, Hans Hsienhong
Chen, Ding-Shinn
Kao, Jia-Horng
Article History
Received: 6 January 2015
Accepted: 25 March 2015
First Online: 12 May 2015
Competing interests
: Jia-Horng Kao: Consultant for Bristol-Myers Squibb, Gilead Sciences and Novartis; on speaker’s bureau for Roche, Bristol-Myers Squibb, Gilead Sciences, Merck Sharp & Dohme and Novartis. Ding-Shinn Chen: Consultant for Bristol-Myers Squibb, Novartis, GlaxoSmithKline, Roche and Merck Sharp & Dohme. All other authors have nothing to declare.